FY25 consensus $4.52. Backs FY25 organic revenue growth of approximately 3% year-over-year, consensus $20.44B. Guidance includes approximate tariff impacts of $265M to adjusted EBIT and 45c to adjusted EPS.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Notable companies reporting before tomorrow’s open
- GE HealthCare receives CE mark for Carevance patient monitor
- GE HealthCare announces collaborations with two medical systems on AI technology
- Intel downgraded, Micron upgraded: Wall Street’s top analyst calls
- GE HealthCare price target raised to $89 from $87 at BTIG